Quarter | Prior | Estimate | Actual | Surprise | |
---|---|---|---|---|---|
Q4 2021 Pre-Market | EPS: REV: | ||||
Q3 2021 Pre-Market | EPS: REV: | 2.75 1.464B | |||
Q2 2021 Pre-Market | EPS: REV: | ||||
Q1 2021 Pre-Market | EPS: REV: | 1.95 1.506B | |||
Q4 2020 Pre-Market | EPS: REV: | 3.62 1.53B | 3.03 1.46B | 3.52 1.541B | 16.17% 5.55% |
Q3 2020 Pre-Market | EPS: REV: | 3.5 1.558B | 2.6 1.46B | 2.75 1.464B | 5.77% 0.27% |
Q2 2020 Pre-Market | EPS: REV: | 3.37 1.554B | 1.59 1.47B | 1.76 1.444B | 10.69% -1.77% |
Q1 2020 Pre-Market | EPS: REV: | 3.38 1.551B | 2.47 1.48B | 1.95 1.506B | -21.05% 1.76% |
Q4 2019 Pre-Market | EPS: REV: | 3.79 1.54B | 3.47 1.52B | 3.62 1.53B | 4.32% 0.66% |
Q3 2019 Pre-Market | EPS: REV: | 3.56 1.488B | 3.57 1.53B | 3.5 1.558B | -1.96% 1.83% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- A Peek Into The Markets: US Stock Futures Up; Treasury Yields Retreat
- 5 Stocks To Watch For March 9, 2021
- Earnings Scheduled For March 9, 2021
- Casey's General Stores: Q3 Earnings Insights
- Penn Virginia: Q4 Earnings Insights
- Recap: Infrastructure and Energy Q4 Earnings
- Recap: Mohawk Gr Hldgs Q4 Earnings
- National CineMedia: Q4 Earnings Insights
- Castle Biosciences: Q4 Earnings Insights
- Syndax Pharmaceuticals: Q4 Earnings Insights